MAPK3 and Alzheimer disease: Specific dysfunctions in skin fibroblasts from AD patients with diagnostic potential have included abnormalities in K + channels24, PKC isozymes25–27, MAP Kinase ERK1/22,14, folate binding28, and cholesterol processing29.